載入...

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

BACKGROUND: The basal-like breast cancer (BLBC) subtype is characterized by positive staining for basal mammary epithelial cytokeratin markers, lack of hormone receptor and HER2 expression, and poor prognosis with currently no approved molecularly-targeted therapies. The oncogenic signaling pathways...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Cancer
Main Authors: She, Qing-Bai, Gruvberger-Saal, Sofia K., Maurer, Matthew, Chen, Yilun, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Lau, Ying-Ka Ingar, Memeo, Lorenzo, Horlings, Hugo M., van de Vijver, Marc J., Isola, Jorma, Hibshoosh, Hanina, Rosen, Neal, Parsons, Ramon, Saal, Lao H.
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4971667/
https://ncbi.nlm.nih.gov/pubmed/27484095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2609-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!